Literature DB >> 10803536

Low-dose melphalan in elderly acute myeloid leukaemia: complete remissions but resistant relapse with therapy-related karyotypes.

R Kerr, J Cunningham, D T Bowen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10803536     DOI： 10.1038/sj.leu.2401762

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Durable second complete remissions with oral melphalan in hypocellular Acute Myeloid Leukemia and Refractory Anemia with Excess Blast with normal karyotype relapsing after intensive chemotherapy.

Authors:  Annika M Whittle; Sylvia Feyler; David T Bowen
Journal:  Leuk Res Rep       Date:  2013-01-11

Review 2.  Drug Repurposing for the Treatment of Acute Myeloid Leukemia.

Authors:  Vibeke Andresen; Bjørn T Gjertsen
Journal:  Front Med (Lausanne)       Date:  2017-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.